Search
Close this search box.

NIIMBL Event

March 27, 2024 |
Webinar

NIIMBL Webinar: Evaluating Next-generation Sequencing (NGS) as an Alternative Method for Replacing the In Vivo and In Vitro Adventitious Virus Detection Assays

Join us for our next NIIMBL webinar focused on the next-generation sequencing for virus detection assays.

This webinar is open to NIIMBL members and federal stakeholders only.

March 27, 2024 | noon ET
Evaluating Next-generation Sequencing (NGS) as an Alternative Method for Replacing the In Vivo and In Vitro Adventitious Virus Detection Assays
Presented by Arifa Khan, FDA

This study has evaluated NGS as an alternative method for adventitious virus detection by conducting a head-to-head comparison with the compendial in vivo animal assays and in vitro cell culture assays. Results of virus detection in the background of CHO cell bioreactor material will be discussed.

Note: Webinar access details will be emailed the evening before the webinar.

If you have questions, please contact us at communications@niimbl.org.

Join Our Mailing List

MailChimp NIIMBL Mailing List Signup
Organization Type
How did you first hear about NIIMBL?